PROTOCOL’S FROM HOSPITAL OF XI’ANG JIAONTONG UNIVERSITY
The protocols below are being published on this page to empower our people about various modalities that are in existence to combat COVID-19 and other diseases. THIS IS NOT A MEDICAL RECOMMENDATION AND NOR IS THIS AN ENDORSEMENT OF THE PROTOCOL. This is being published so that anyone who may have COVID-19, or who may be a caregiver of someone with COVID-19, can discuss this information with their health care providers. We make decisions about our illnesses based on knowledge, based on options that we are told about! If we don’t know about alternatives and other options, we will never choose them. And the more informed we are about various treatments, the better our chances are of combating a disease and of thriving. So we need to know about various modalities that are in use. So please, print this information out NOW and present this to your health care provider so that you can come up with a plan of action! And should you become sick with COVID-19 and should need to be hospitalized, talk with the hospital about these protocols as well. And since they will feed you in the hospital, you can tell them that you want Vitamin C to be a part of your nutritional therapy. The below protocol refers specifically to pneumonia, and not to COVID-19 and appears to refer to the early stages of the outbreak. But remember, the advanced stage COVID-19 is pneumonia. Also, as the website is in Chinese, google translation services was used. And lastly, at the end of this article are more studies and links to Vitamin C therapy. These studies are taken from peer reviewed modern medical sources.
High-dose vitamin C treatment of new coronary pneumonia
Release time: 2020-02-21 11:00:56 Views: 19485
1). On the afternoon of February 20, 2020, another 4 patients with severe neocoronary pneumonia recovered from the C10 West Ward of Tongji Hospital in the Tongji Hospital, which was taken over by the Second Aid National Medical Assistance Team of Xi’an Jiaotong University. The medical team was formally put into work10 In the past 8 patients have been discharged from hospital.
2). After 10 days of practical exploration by the medical team and repeated discussions by the expert group, our expert group proposed a specific plan for the combination of high-dose vitamin C to treat the new crown, and achieved good results in clinical applications. Our treatment plan is generally summarized as “early, adequate, short course, combined.”
3). Early stage: The so-called “early stage” refers to the timely application of high-dose vitamin C in the early stages of the disease course. We believe that for patients with severe neonatal pneumonia and critically ill patients, vitamin C treatment should be initiated as soon as possible after admission. This is because no matter the past Keshan disease, SARS and Middle East respiratory syndrome, or the current new pneumonia, the main cause of death of patients is cardiopulmonary failure caused by increased acute oxidative stress. When the virus causes increased oxidative stress in the body and increased capillary permeability, early application of large doses of vitamin C can have a strong antioxidant effect, reduce inflammatory responses, and improve endothelial function.
4). Adequate: Adequate refers to the large amount of vitamin C. Numerous studies have shown that the dose of vitamin C has a lot to do with the effect of treatment. Our past experience in successfully rescuing acute Keshan disease and current studies at home and abroad show that high-dose vitamin C can not only improve antiviral levels, but more importantly, can prevent and treat acute lung injury (ALI) and acute respiratory distress (ARDS). .
5). Short-term: Short-term means that the medication time does not exceed 1 week. Short-term application of large doses of vitamin C in the critical period of disease progression can achieve twice the result with half the effort, and can significantly reduce the side effects such as kidney stones, hematuria and renal colic that should be brought in the long term, reduce nausea, vomiting, hypotension, tachycardia, etc Adverse reactions to avoid the body’s dependence on exogenous vitamin C caused by long-term medication.
6). Combination: Combination refers to the combination of other treatment methods in the treatment process to develop individualized treatment plans. New crown pneumonia treatment is still without specific drugs. In the just-released “New Crown Pneumonia Diagnosis and Treatment Program Sixth Edition”, it is recommended that active symptomatic treatment be based on early trials of antiviral therapy and oxygen therapy. Therefore, the clinical application of high-dose vitamin C must be combined with the patient’s situation and combined with other drugs and treatment methods, so that it is expected to improve the treatment of critically ill patients.
7). In addition, when using this regimen, it should be noted that due to the high concentration, it may irritate the blood vessels and cause pain. It is recommended that isotonic fluids be given to flush the blood vessels quickly after administration to reduce the irritation of the blood vessels. In addition, we use intermittent and slow administration. Helps maintain the effective concentration of blood vitamin C, and can also reduce the local stimulation of blood vessels to the greatest extent. Finally, because vitamin C may interfere with blood glucose monitoring results, patients with diabetes should avoid measuring blood glucose immediately after infusion.
8). Finally, based on the various pharmacological properties of vitamin C, this treatment should not be used in patients with the following clinical conditions: 1. Allergy to vitamin C; 2. Life expectancy less than 24h; pregnant and / or lactating women; tracheotomy Have or have a family history of oxygen therapy; 6. Interstitial lung disease, malignancy, diffuse alveolar hemorrhage, diabetic ketoacidosis, or a history of active kidney stones. (End of protocols from hospital).
ADDITIONAL MEDICAL STUDIES ABOUT VITAMIN C THERAPY AND PNEUMONIA
Combined vitamin C, hydrocortisone, and thiamine therapy for patients with severe pneumonia who were admitted to the intensive care unit. https://www.sciencedirect.com/science/article/pii/S0883944118307780?via%3Dihub
Vitamin C for Preventing and Treating Pneumonia Vitamin C was identified in the early 1900s and suggestions that one of its biological roles may be to resist infections are supported by numerous animal studies. We looked for studies in humans and found three trials with a total of 2335 participants that looked at whether vitamin C prevents pneumonia in the community. Two of these preventive trials studied soldiers while the third studied boys in a UK boarding school in the 1940s. Two therapeutic trials with a total of 197 pneumonia patients looked at whether vitamin C might be beneficial for pneumonia patients. One studied patients aged 66 to 94 years in the UK with pneumonia. The other therapeutic trial was conducted in the former Soviet Union but the social and nutritional backgrounds of the patients were not described. One study with 37 burns patients examined the effect of vitamin C on hospital‐acquired pneumonia. Our searches were up‐date‐as of April 2013.
Probiotics, Vitamin E/C and Lung Inflammation In conclusion, our study support that a supplemental nutritional intervention based on a combination of the probiotic B. lactis BB-12, the anti-oxidant vitamin C and E, and the anti-inflammatory docosahexanoic acid represents a rational option for alleviating air pollution-related lung inflammation.
Therapeutic effect of ascorbic acid (Vitamin C) on dapsone-induced methemoglobinemia (blood disease in which the body isn’t getting enough oxygen) in rats. CONCLUSION:Intravenous ascorbic acid administration is effective in treating DDS-induced methemoglobinemia in a murine model.
Intravenous Use of Vitamin C for Acute Respiratory Disease Syndrome We report a case of virus-induced acute respiratory distress syndrome (ARDS) treated with parenteral vitamin C in a patient testing positive for enterovirus/rhinovirus on viral screening. This report outlines the first use of high dose intravenous vitamin C as an interventional therapy for ARDS, resulting from enterovirus/rhinovirus respiratory infection. From very significant preclinical research performed at Virginia Commonwealth University with vitamin C and with the very positive results of a previously performed phase I safety trial infusing high dose vitamin C intravenously into patients with severe sepsis, we reasoned that infusing identical dosing to a patient with ARDS from viral infection would be therapeutic. We report here the case of a 20-year-old, previously healthy, female who contracted respiratory enterovirus/rhinovirus infection that led to acute lung injury and rapidly to ARDS.